Quick Answer
Aquestive Therapeutics, Inc. reported Stockholders Equity of -$33.66 million for fiscal year 2025.
Aquestive Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$33.66M | +44.0% |
| 2024 | -$60.16M | +43.5% |
| 2023 | -$106.49M | +10.2% |
| 2022 | -$118.55M | -44.3% |
| 2021 | -$82.13M | -69.4% |
| 2020 | -$48.50M | -692.2% |
| 2019 | -$6.12M | -160.7% |
| 2018 | $10.08M | +138.0% |
| 2017 | -$26.50M | +53.7% |
| 2016 | -$57.20M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.11M | +91.0% | +94.3% |
| June 30, 2025 | -$72.59M | -104.6% | -19.1% |
| March 31, 2025 | -$60.93M | -67.8% | -1.3% |
| December 31, 2024 | -$60.16M | +43.5% | -32.4% |
| September 30, 2024 | -$45.42M | +55.9% | -28.0% |
| June 30, 2024 | -$35.48M | +66.7% | +2.3% |
| March 31, 2024 | -$36.30M | +66.8% | +65.9% |
| December 31, 2023 | -$106.49M | +10.2% | -3.5% |
- Aquestive Therapeutics, Inc. showed an increase of +44.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Aquestive Therapeutics, Inc.’s stockholders equity has grown by 41.1% (from -$57.20 million to -$33.66 million).
- The most recent figure is from Aquestive Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: